In addition, we discuss recent developments of therapeutic approaches in the treatment of obesity and diabetes by dual- and tri-agonist molecules based on combinations of glucagon with other peptides. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.